The Combined First Trimester Screening
Recruiting
Observational Study
Preeclampsia (PE)
Fetal Growth Restriction
Congenital Abnormalities
Preterm Labor
Intrauterine Fetal Demise
Genetics Syndrome
Pregnancy Overdue - Week 41+6
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- Institute of Health Information and Statistics of the Czech Republic · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The project is a national, prospective, multicenter pilot project. The project is focus on setting up the combined first trimester screening in the Czech Republic.
The combined first trimester screening is aimed at predicting and detecting the most serious obstetric complications, such as the great obstetrical syndromes (preeclampsia, fetal growth restriction, preterm labor and intrauterine fetal…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* A woman over 18 years old in the first trimester of pregnancy (11th-13th gestational week)
* Signed the Consent to Participate in the Project and GDPR.
Exclusion Criteria:
* Unsigned the Consent to Participate in the Project and the Consent to the Processing of Personal Data…
Contacts